{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:44:36Z","timestamp":1792669476920,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was supported by the Tianshan Talents Program for Medical and Health High-Level Talents Training Plan of the Health Commission of Xinjiang Uygur Autonomous Region","award":["TSYC202301B032"],"award-info":[{"award-number":["TSYC202301B032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12991-5","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:27:10Z","timestamp":1792668430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-induced GP73 promotes the Warburg effect in hepatocellular carcinoma via HIF-1\u03b1"],"prefix":"10.1007","volume":"53","author":[{"given":"Mierkamilijiang","family":"Abudureheman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"8","key":"12991_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/cancers16081582","volume":"16","author":"S Zheng","year":"2024","unstructured":"Zheng S, Chan SW, Liu F, Liu J, Chow PKH et al (2024) Hepatocellular carcinoma: current drug therapeutic status, advances and challenges. Cancers 16(8):1582. https:\/\/doi.org\/10.3390\/cancers16081582","journal-title":"Cancers"},{"issue":"10","key":"12991_CR2","doi-asserted-by":"publisher","first-page":"e04261","DOI":"10.1002\/adhm.202504261","volume":"15","author":"X Lv","year":"2026","unstructured":"Lv X, Ma M, Zhao Z, Li Y, Kong J et al (2026) Degradable multifunctional microspheres for combined thermotherapy-embolization-immune activation therapy of hepatocellular carcinoma. Adv Healthc Mater 15(10):e04261. https:\/\/doi.org\/10.1002\/adhm.202504261","journal-title":"Adv Healthc Mater"},{"key":"12991_CR3","doi-asserted-by":"publisher","first-page":"963966","DOI":"10.3389\/fonc.2023.963966","volume":"13","author":"SSR Vulasala","year":"2023","unstructured":"Vulasala SSR, Sutphin PD, Kethu S, Onteddu NK, Kalva SP (2023) Interventional radiological therapies in colorectal hepatic metastases. Front Oncol 13:963966. https:\/\/doi.org\/10.3389\/fonc.2023.963966","journal-title":"Front Oncol"},{"issue":"5","key":"12991_CR4","doi-asserted-by":"publisher","first-page":"100720","DOI":"10.1016\/j.aohep.2022.100720","volume":"27","author":"MY Liu","year":"2022","unstructured":"Liu MY, Huang L, Wu JF, Zhang HB, Ai WB, Zhang RT (2022) Possible roles of Golgi protein-73 in liver diseases. Ann Hepatol 27(5):100720. https:\/\/doi.org\/10.1016\/j.aohep.2022.100720","journal-title":"Ann Hepatol"},{"issue":"1","key":"12991_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/07853890.2022.2153163","volume":"55","author":"BY Pang","year":"2023","unstructured":"Pang BY, Leng Y, Wang X, Wang YQ, Jiang LH (2023) A meta-analysis of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma. Ann Med 55(1):42\u201361. https:\/\/doi.org\/10.1080\/07853890.2022.2153163","journal-title":"Ann Med"},{"issue":"1","key":"12991_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12876-023-03050-5","volume":"23","author":"WM Yu","year":"2023","unstructured":"Yu WM, Li GW, Lou MG, Wu ZY (2023) A meta-analysis of the prognostic impact of tissue Golgi protein 73 (tGP73) in hepatocellular carcinoma. BMC Gastroenterol 23(1):401. https:\/\/doi.org\/10.1186\/s12876-023-03050-5","journal-title":"BMC Gastroenterol"},{"key":"12991_CR7","doi-asserted-by":"publisher","first-page":"783860","DOI":"10.3389\/fonc.2021.783860","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Hu X, Liu S, Zhou S, Chen Z, Jin H (2021) Golgi phosphoprotein 73: the driver of epithelial-mesenchymal transition in cancer. Front Oncol 11:783860. https:\/\/doi.org\/10.3389\/fonc.2021.783860","journal-title":"Front Oncol"},{"issue":"1","key":"12991_CR8","doi-asserted-by":"publisher","first-page":"e10375","DOI":"10.1002\/btm2.10375","volume":"8","author":"L Yang","year":"2022","unstructured":"Yang L, Li J, Zang G, Song S, Sun Z, Li X et al (2022) Pin1\/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism. Bioeng Transl Med 8(1):e10375. https:\/\/doi.org\/10.1002\/btm2.10375","journal-title":"Bioeng Transl Med"},{"key":"12991_CR9","doi-asserted-by":"publisher","first-page":"175535","DOI":"10.1016\/j.ejphar.2023.175535","volume":"943","author":"S Ghafouri-Fard","year":"2023","unstructured":"Ghafouri-Fard S, Hussen BM, Shoorei H, Abak A, Poornajaf Y et al (2023) Interactions between non-coding RNAs and HIF-1\u03b1 in the context of cancer. Eur J Pharmacol 943:175535. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175535","journal-title":"Eur J Pharmacol"},{"key":"12991_CR10","doi-asserted-by":"publisher","first-page":"0425","DOI":"10.34133\/research.0425","volume":"7","author":"Y Liu","year":"2024","unstructured":"Liu Y, Hu X, Zhou S, Sun T, Shen F, Zeng L (2024) Golgi protein 73 promotes angiogenesis in hepatocellular carcinoma. Res (Wash D C) 7:0425. https:\/\/doi.org\/10.34133\/research.0425","journal-title":"Res (Wash D C)"},{"issue":"11","key":"12991_CR11","doi-asserted-by":"publisher","first-page":"107906","DOI":"10.1016\/j.jbc.2024.107906","volume":"300","author":"SJ Kierans","year":"2024","unstructured":"Kierans SJ, Taylor CT (2024) Glycolysis: a multifaceted metabolic pathway and signaling hub. J Biol Chem 300(11):107906. https:\/\/doi.org\/10.1016\/j.jbc.2024.107906","journal-title":"J Biol Chem"},{"issue":"3","key":"12991_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1021\/acsptsci.3c00301","volume":"7","author":"R Akter","year":"2024","unstructured":"Akter R, Awais M, Boopathi V, Ahn JC, Yang DC et al (2024) Inversion of the Warburg effect: unraveling the metabolic nexus between obesity and cancer. ACS Pharmacol Transl Sci 7(3):560\u2013569. https:\/\/doi.org\/10.1021\/acsptsci.3c00301","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"12991_CR13","doi-asserted-by":"publisher","first-page":"e009265","DOI":"10.1136\/jitc-2024-009265","volume":"13","author":"J Liu","year":"2025","unstructured":"Liu J, Feng C, Zhao R, Song H, Huang L et al (2025) GP73 reinforces cytotoxic T-cell function by regulating HIF-1\u03b1 and increasing antitumor efficacy. J Immunother Cancer 13(1):e009265. https:\/\/doi.org\/10.1136\/jitc-2024-009265","journal-title":"J Immunother Cancer"},{"issue":"19","key":"12991_CR14","doi-asserted-by":"publisher","first-page":"11363","DOI":"10.3390\/ijms231911363","volume":"23","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Ricci AD (2022) Challenges and future trends of hepatocellular carcinoma immunotherapy. Int J Mol Sci 23(19):11363. https:\/\/doi.org\/10.3390\/ijms231911363","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12991_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5306\/wjco.v15.i1.62","volume":"15","author":"JZ Huang","year":"2024","unstructured":"Huang JZ, Li JD, Chen G, He RQ (2024) Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma. World J Clin Oncol 15(1):62\u201388. https:\/\/doi.org\/10.5306\/wjco.v15.i1.62","journal-title":"World J Clin Oncol"},{"issue":"18","key":"12991_CR16","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.3390\/cancers14184428","volume":"14","author":"SH Loosen","year":"2022","unstructured":"Loosen SH, Halpaap J, Labuhn S, Bednarsch J, Alizai PH et al (2022) Golgi protein 73 (GP73) serum levels predict outcome after resection of biliary tract cancer. Cancers 14(18):4428. https:\/\/doi.org\/10.3390\/cancers14184428","journal-title":"Cancers"},{"issue":"5","key":"12991_CR17","doi-asserted-by":"publisher","first-page":"e011989","DOI":"10.1136\/jitc-2025-011989","volume":"13","author":"RJ Bayliss","year":"2025","unstructured":"Bayliss RJ, Parker AL (2025) GP73: the key to unlocking immunotherapies efficacy in solid tumors? J Immunother Cancer 13(5):e011989. https:\/\/doi.org\/10.1136\/jitc-2025-011989","journal-title":"J Immunother Cancer"},{"issue":"1","key":"12991_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13027-022-00462-y","volume":"17","author":"L Liu","year":"2022","unstructured":"Liu L, Huang Y, Fu Y, Rao J, Zeng F et al (2022) Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response. Infect Agents Cancer 17(1):52. https:\/\/doi.org\/10.1186\/s13027-022-00462-y","journal-title":"Infect Agents Cancer"},{"issue":"5","key":"12991_CR19","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1111\/dom.70612","volume":"28","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Ji JL, Yao DD, Zhou Y, Liu CC et al (2026) Oxaloacetate restores HIF-1\u03b1-mediated mitochondrial homeostasis to counter tubulointerstitial injury in diabetic kidney disease. Diabetes Obes Metab 28(5):4216\u20134231. https:\/\/doi.org\/10.1111\/dom.70612","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"12991_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41419-022-05008-z","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Deng H, Tang J, Wang Z, Zhu C et al (2022) OTUB1 augments hypoxia signaling via its non-canonical ubiquitination inhibition of HIF-1\u03b1 during hypoxia adaptation. Cell Death Dis 13(6):560. https:\/\/doi.org\/10.1038\/s41419-022-05008-z","journal-title":"Cell Death Dis"},{"issue":"3","key":"12991_CR21","doi-asserted-by":"publisher","first-page":"368504211026417","DOI":"10.1177\/00368504211026417","volume":"104","author":"T Wu","year":"2021","unstructured":"Wu T, Yao Y, Sun R, Wang H, Zhang J et al (2021) Arterial instillation of rapamycin in treatment of rabbit hepatic xenograft tumors and its effects on VEGF, iNOS, HIF-1\u03b1, Bcl-2, Bax expression and microvessel density. Sci Prog 104(3):368504211026417. https:\/\/doi.org\/10.1177\/00368504211026417","journal-title":"Sci Prog"},{"issue":"6","key":"12991_CR22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s12094-022-03055-8","volume":"25","author":"Y Xu","year":"2023","unstructured":"Xu Y, Ren B, Wang M (2023) HIF-1\u03b1 contributes to metastasis in choriocarcinoma by regulating DEC1 expression. Clin Transl Oncol 25(6):1641\u20131649. https:\/\/doi.org\/10.1007\/s12094-022-03055-8","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"12991_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ijc.70515","volume":"159","author":"S Li","year":"2026","unstructured":"Li S, Liu Y, Liu X, Wang X, Li W, Song M et al (2026) Targeting HIF as a promising approach to synergize with immune checkpoint inhibitors. Int J Cancer 159(5):1109\u20131123. https:\/\/doi.org\/10.1002\/ijc.70515","journal-title":"Int J Cancer"},{"issue":"1","key":"12991_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-023-02724-y","volume":"42","author":"TW Kao","year":"2023","unstructured":"Kao TW, Bai GH, Wang TL, Shih IM, Chuang CM et al (2023) Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance. J Exp Clin Cancer Res 42(1):171. https:\/\/doi.org\/10.1186\/s13046-023-02724-y","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12991-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12991-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12991-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:27:11Z","timestamp":1792668431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12991-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12991"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12991-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the First Affiliated Hospital of Xinjiang Medical University. The clinical sample collection involving human participants was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all patients prior to blood sample collection. The in vitro cell-based experiments using the commercially available HepG2 cell line did not require additional ethical approval.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1785"}}